Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA damage repair pathway refers to a collection of highly conserved cellular mechanisms that detect, signal, and repair various forms of DNA damage to maintain genomic stability. These pathways are essential for correcting errors or lesions in the DNA that arise from endogenous metabolic processes or exogenous sources such as radiation and chemicals. Failure in these pathways can lead to mutations, genomic instability, cancer development, and other diseases. Key pathways include Direct Reversal, Base Excision Repair (BER), Nucleotide Excision Repair (NER), Mismatch Repair (MMR), Homologous Recombination (HR/HRR), and Non-Homologous End Joining (NHEJ).
Varies depending on the specific drug and pathway. Examples include inhibition of DNA repair enzymes, induction of DNA damage, and synthetic lethality.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Damage Repair Pathway (DDR).